Design of PLGA Based Nanoparticles for Imaging Guided Applications
- Autores
- Mariano, Rodolfo Nicolás; Alberti, Diego Javier; Cutrin, Juan Carlos; Geninatti Crich, Simonetta; Aime, Silvio
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- An amphiphilic Gd(III) complex has been efficiently loaded in polylactic-co-glycolic acid nanoparticles (PLGA-NPs) to yield a novel, high sensitive magnetic resonance imaging (MRI) contrast agent for imaging guided drug delivery applications. As the Gd(III) complex is soluble in organic solvents, the nanoparticles were prepared as oil/water emulsions. PLGA-NPs were stable, in buffer, for more than 1 week without any release of the incorporated agents. The millimolar relaxivity of the Gd(III) complex incorporated in the particles (140 nm diameter) was of 21.7 mM(-1) s(-1) at 21.5 MHz, a value that is about 5 times higher than that observed with the commercially available contrast agents used in clinic. The relaxometric efficiency of these particles resulted inversely proportional to the particle size measured by dynamic light scattering. The high stability and sensitivity of PLGA-NPs allowed their accumulation in vivo in murine melanoma xenograft as shown in the corresponding MR images. Once loaded with drug and contrast agents, PLGA nanoparticles can be proposed as efficient theranostic MRI agents.
Fil: Mariano, Rodolfo Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina
Fil: Alberti, Diego. Università di Torino; Italia
Fil: Cutrin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina
Fil: Geninatti Crich, Simonetta. Università di Torino; Italia
Fil: Aime, Silvio. Università di Torino; Italia - Materia
-
Gd(Iii) Complexes
Mri
Contrast Agents
Imaging Guided Therapy
Plga
Nanoparticles - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/30786
Ver los metadatos del registro completo
id |
CONICETDig_ac2413df8798e5a80ccb0134220ef3fc |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/30786 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Design of PLGA Based Nanoparticles for Imaging Guided ApplicationsMariano, Rodolfo NicolásAlberti, Diego JavierCutrin, Juan CarlosGeninatti Crich, SimonettaAime, SilvioGd(Iii) ComplexesMriContrast AgentsImaging Guided TherapyPlgaNanoparticleshttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3An amphiphilic Gd(III) complex has been efficiently loaded in polylactic-co-glycolic acid nanoparticles (PLGA-NPs) to yield a novel, high sensitive magnetic resonance imaging (MRI) contrast agent for imaging guided drug delivery applications. As the Gd(III) complex is soluble in organic solvents, the nanoparticles were prepared as oil/water emulsions. PLGA-NPs were stable, in buffer, for more than 1 week without any release of the incorporated agents. The millimolar relaxivity of the Gd(III) complex incorporated in the particles (140 nm diameter) was of 21.7 mM(-1) s(-1) at 21.5 MHz, a value that is about 5 times higher than that observed with the commercially available contrast agents used in clinic. The relaxometric efficiency of these particles resulted inversely proportional to the particle size measured by dynamic light scattering. The high stability and sensitivity of PLGA-NPs allowed their accumulation in vivo in murine melanoma xenograft as shown in the corresponding MR images. Once loaded with drug and contrast agents, PLGA nanoparticles can be proposed as efficient theranostic MRI agents.Fil: Mariano, Rodolfo Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; ArgentinaFil: Alberti, Diego. Università di Torino; ItaliaFil: Cutrin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; ArgentinaFil: Geninatti Crich, Simonetta. Università di Torino; ItaliaFil: Aime, Silvio. Università di Torino; ItaliaAmerican Chemical Society2014-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/30786Mariano, Rodolfo Nicolás; Alberti, Diego Javier; Cutrin, Juan Carlos; Geninatti Crich, Simonetta; Aime, Silvio; Design of PLGA Based Nanoparticles for Imaging Guided Applications; American Chemical Society; Molecular Pharmaceutics; 11; 11; 9-2014; 4100-41061543-8384CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://pubs.acs.org/doi/abs/10.1021/mp5002747info:eu-repo/semantics/altIdentifier/doi/10.1021/mp5002747info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:01:30Zoai:ri.conicet.gov.ar:11336/30786instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:01:31.277CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Design of PLGA Based Nanoparticles for Imaging Guided Applications |
title |
Design of PLGA Based Nanoparticles for Imaging Guided Applications |
spellingShingle |
Design of PLGA Based Nanoparticles for Imaging Guided Applications Mariano, Rodolfo Nicolás Gd(Iii) Complexes Mri Contrast Agents Imaging Guided Therapy Plga Nanoparticles |
title_short |
Design of PLGA Based Nanoparticles for Imaging Guided Applications |
title_full |
Design of PLGA Based Nanoparticles for Imaging Guided Applications |
title_fullStr |
Design of PLGA Based Nanoparticles for Imaging Guided Applications |
title_full_unstemmed |
Design of PLGA Based Nanoparticles for Imaging Guided Applications |
title_sort |
Design of PLGA Based Nanoparticles for Imaging Guided Applications |
dc.creator.none.fl_str_mv |
Mariano, Rodolfo Nicolás Alberti, Diego Javier Cutrin, Juan Carlos Geninatti Crich, Simonetta Aime, Silvio |
author |
Mariano, Rodolfo Nicolás |
author_facet |
Mariano, Rodolfo Nicolás Alberti, Diego Javier Cutrin, Juan Carlos Geninatti Crich, Simonetta Aime, Silvio |
author_role |
author |
author2 |
Alberti, Diego Javier Cutrin, Juan Carlos Geninatti Crich, Simonetta Aime, Silvio |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Gd(Iii) Complexes Mri Contrast Agents Imaging Guided Therapy Plga Nanoparticles |
topic |
Gd(Iii) Complexes Mri Contrast Agents Imaging Guided Therapy Plga Nanoparticles |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
An amphiphilic Gd(III) complex has been efficiently loaded in polylactic-co-glycolic acid nanoparticles (PLGA-NPs) to yield a novel, high sensitive magnetic resonance imaging (MRI) contrast agent for imaging guided drug delivery applications. As the Gd(III) complex is soluble in organic solvents, the nanoparticles were prepared as oil/water emulsions. PLGA-NPs were stable, in buffer, for more than 1 week without any release of the incorporated agents. The millimolar relaxivity of the Gd(III) complex incorporated in the particles (140 nm diameter) was of 21.7 mM(-1) s(-1) at 21.5 MHz, a value that is about 5 times higher than that observed with the commercially available contrast agents used in clinic. The relaxometric efficiency of these particles resulted inversely proportional to the particle size measured by dynamic light scattering. The high stability and sensitivity of PLGA-NPs allowed their accumulation in vivo in murine melanoma xenograft as shown in the corresponding MR images. Once loaded with drug and contrast agents, PLGA nanoparticles can be proposed as efficient theranostic MRI agents. Fil: Mariano, Rodolfo Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina Fil: Alberti, Diego. Università di Torino; Italia Fil: Cutrin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina Fil: Geninatti Crich, Simonetta. Università di Torino; Italia Fil: Aime, Silvio. Università di Torino; Italia |
description |
An amphiphilic Gd(III) complex has been efficiently loaded in polylactic-co-glycolic acid nanoparticles (PLGA-NPs) to yield a novel, high sensitive magnetic resonance imaging (MRI) contrast agent for imaging guided drug delivery applications. As the Gd(III) complex is soluble in organic solvents, the nanoparticles were prepared as oil/water emulsions. PLGA-NPs were stable, in buffer, for more than 1 week without any release of the incorporated agents. The millimolar relaxivity of the Gd(III) complex incorporated in the particles (140 nm diameter) was of 21.7 mM(-1) s(-1) at 21.5 MHz, a value that is about 5 times higher than that observed with the commercially available contrast agents used in clinic. The relaxometric efficiency of these particles resulted inversely proportional to the particle size measured by dynamic light scattering. The high stability and sensitivity of PLGA-NPs allowed their accumulation in vivo in murine melanoma xenograft as shown in the corresponding MR images. Once loaded with drug and contrast agents, PLGA nanoparticles can be proposed as efficient theranostic MRI agents. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/30786 Mariano, Rodolfo Nicolás; Alberti, Diego Javier; Cutrin, Juan Carlos; Geninatti Crich, Simonetta; Aime, Silvio; Design of PLGA Based Nanoparticles for Imaging Guided Applications; American Chemical Society; Molecular Pharmaceutics; 11; 11; 9-2014; 4100-4106 1543-8384 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/30786 |
identifier_str_mv |
Mariano, Rodolfo Nicolás; Alberti, Diego Javier; Cutrin, Juan Carlos; Geninatti Crich, Simonetta; Aime, Silvio; Design of PLGA Based Nanoparticles for Imaging Guided Applications; American Chemical Society; Molecular Pharmaceutics; 11; 11; 9-2014; 4100-4106 1543-8384 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://pubs.acs.org/doi/abs/10.1021/mp5002747 info:eu-repo/semantics/altIdentifier/doi/10.1021/mp5002747 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Chemical Society |
publisher.none.fl_str_mv |
American Chemical Society |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613809954619392 |
score |
13.070432 |